Musculoskeletal Tumor Center
Beijing, Beijing Municipality, 100044, China
Location status: Recruiting
NCT Number: NCT06778603
Complete removal of all tumor tissue with a wide surgical margin is essential for the treatment of osteosarcoma (OS). However, it's difficult, sometimes impossible, to achieve due to the invisible small satellite lesions and blurry tumor boundaries. Besides, intraoperative frozen-section analysis of resection margins of OS is often restricted by the hard tissues around OS, which makes it impossible to know whether a negative margin is achieved. Herein, based on the high expression of B7-H3 in OS, a targeted probe B7H3-IRDye800CW is synthesized by conjugating anti-B7H3 antibody and IRDye800CW. This trial is aimed to investigate R0-resection rate and 2-y local recurrence rate after using this probe in Musculoskeletal tumor surgery for osteosarcoma as well as the safety parameters of this probe in human.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Phase 1 / Phase 2
Beijing, Beijing Municipality, 100044, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
B7H3-IRDye800CW was synthesized by conjugating IRDye800CW NHS Ester and Anti-B7H3 antibody.
Time frame: 21 days
According to CTCAE 5.0
Contact information is provided by the study sponsor or research team.
Peking University People's Hospital
Other
Resection of Osteosarcoma in Limbs Navigated by B7H3-based NIR Lmaging: a Prospective, Single-center,Single-arm, Exploratory Trial
Acronym: ROLN-B7-H3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04616560
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor
Birmingham, Alabama, United States
View Trial DetailsNCT04040205
Chondrosarcoma, Eye Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT05227326
Adnexal Diseases, Bronchial Neoplasms
Scottsdale, Arizona, United States
View Trial DetailsNCT07725380
Neoplasms, Neoplasms by Histologic Type
Tampa, Florida, United States
View Trial Details